ESTA logo

ESTA Stock Overview

Profile

Full Name:

Establishment Labs Holdings Inc.

Sector:

Healthcare

Country:

Costa Rica

IPO:

July 19, 2018

Indexes:

Not included

Description:

Establishment Labs Holdings is a medical technology company that specializes in developing and manufacturing innovative breast implants and related products. Their focus is on enhancing patient safety and outcomes through advanced design and technology, catering to both aesthetic and reconstructive surgery markets.

Key Details

Price

$28.51

Annual Revenue

$165.15 M(+2.13% YoY)

Annual EPS

-$3.07(+0.32% YoY)

Annual ROE

-1537.75%

Beta

1.90

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Oct 14, 24 BTIG
Buy
Oct 1, 24 Citigroup
Neutral
Aug 22, 24 Citigroup
Neutral
Aug 7, 24 Stephens & Co.
Overweight
Aug 7, 24 JP Morgan
Overweight
Jul 11, 24 Citigroup
Neutral
Jun 6, 24 Mizuho
Buy
May 22, 24 Citigroup
Neutral
Apr 3, 24 Citigroup
Buy
Apr 1, 24 Mizuho
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
ESTA
seekingalpha.comNovember 9, 2024

Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Conference Call Participants Allen Gong - JPMorgan Matt Taylor - Jefferies Sam Eiber - BTIG Anthony Pettinari - Citi Josh Jennings - TD Cowen Anthony Petrone - Mizuho Group Operator Good afternoon. Welcome to Establishment Labs Third Quarter 2024 Earnings Conference Call.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
ESTA
zacks.comNovember 7, 2024

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago.

Establishment Labs Announces $50 Million Registered Direct Offering
Establishment Labs Announces $50 Million Registered Direct Offering
Establishment Labs Announces $50 Million Registered Direct Offering
ESTA
businesswire.comNovember 7, 2024

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of 765,696 common shares and pre-funded warrants to purchase up to 328,161 common shares in a registered direct offering for a.

Establishment Labs Receives U.S. FDA Approval for Motiva Implants
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
ESTA
businesswire.comSeptember 26, 2024

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
ESTA
zacks.comAugust 6, 2024

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.

Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains?
ESTA
zacks.comJune 25, 2024

Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript
ESTA
Seeking AlphaFebruary 28, 2024

Establishment Labs Holdings Inc. (ESTA) Q4 2023 Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
ESTA
Zacks Investment ResearchFebruary 28, 2024

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.55 per share a year ago.

Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
ESTA
Zacks Investment ResearchFebruary 21, 2024

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Establishment Labs Stock Is Crashing Today
Why Establishment Labs Stock Is Crashing Today
Why Establishment Labs Stock Is Crashing Today
ESTA
The Motley FoolNovember 8, 2023

Establishment Labs missed consensus revenue and earnings estimates in Q3. The company also slashed its full-year guidance.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for Establishment Labs Holdings?
  • Does Establishment Labs Holdings pay dividends?
  • What sector is Establishment Labs Holdings in?
  • What industry is Establishment Labs Holdings in?
  • What country is Establishment Labs Holdings based in?
  • When did Establishment Labs Holdings go public?
  • Is Establishment Labs Holdings in the S&P 500?
  • Is Establishment Labs Holdings in the NASDAQ 100?
  • Is Establishment Labs Holdings in the Dow Jones?
  • When was Establishment Labs Holdings's last earnings report?
  • When does Establishment Labs Holdings report earnings?
  • Should I buy Establishment Labs Holdings stock now?

What is the ticker symbol for Establishment Labs Holdings?

The ticker symbol for Establishment Labs Holdings is NASDAQ:ESTA

Does Establishment Labs Holdings pay dividends?

No, Establishment Labs Holdings does not pay dividends

What sector is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Healthcare sector

What industry is Establishment Labs Holdings in?

Establishment Labs Holdings is in the Medical Devices industry

What country is Establishment Labs Holdings based in?

Establishment Labs Holdings is headquartered in Costa Rica

When did Establishment Labs Holdings go public?

Establishment Labs Holdings's initial public offering (IPO) was on July 19, 2018

Is Establishment Labs Holdings in the S&P 500?

No, Establishment Labs Holdings is not included in the S&P 500 index

Is Establishment Labs Holdings in the NASDAQ 100?

No, Establishment Labs Holdings is not included in the NASDAQ 100 index

Is Establishment Labs Holdings in the Dow Jones?

No, Establishment Labs Holdings is not included in the Dow Jones index

When was Establishment Labs Holdings's last earnings report?

Establishment Labs Holdings's most recent earnings report was on Nov 7, 2024

When does Establishment Labs Holdings report earnings?

The next expected earnings date for Establishment Labs Holdings is Feb 28, 2025

Should I buy Establishment Labs Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions